143 related articles for article (PubMed ID: 21235413)
1. Pandemic 2009 H1N1 influenza virus is resistant to the antiviral activity of several interferon alpha subtypes.
Scagnolari C; Trombetti S; Soldà A; Selvaggi C; Monteleone K; Spano L; Pierangeli A; Clementi M; Turriziani O; Antonelli G
J Interferon Cytokine Res; 2011 Jun; 31(6):475-9. PubMed ID: 21235413
[TBL] [Abstract][Full Text] [Related]
2. Low-dose interferon Type I treatment is effective against H5N1 and swine-origin H1N1 influenza A viruses in vitro and in vivo.
Haasbach E; Droebner K; Vogel AB; Planz O
J Interferon Cytokine Res; 2011 Jun; 31(6):515-25. PubMed ID: 21323570
[TBL] [Abstract][Full Text] [Related]
3. Antiviral potential of exogenous human omega interferon to inhibit pandemic 2009 A (H1N1) influenza virus.
Xu C; Song X; Fu L; Dong D; Wu S; Li G; Yi S; Yu T; Yu R; Hou L; Chen W
Viral Immunol; 2011 Oct; 24(5):369-74. PubMed ID: 22004136
[TBL] [Abstract][Full Text] [Related]
4. Pandemic H1N1 2009 influenza A virus induces weak cytokine responses in human macrophages and dendritic cells and is highly sensitive to the antiviral actions of interferons.
Osterlund P; Pirhonen J; Ikonen N; Rönkkö E; Strengell M; Mäkelä SM; Broman M; Hamming OJ; Hartmann R; Ziegler T; Julkunen I
J Virol; 2010 Feb; 84(3):1414-22. PubMed ID: 19939920
[TBL] [Abstract][Full Text] [Related]
5. Antiviral activity of the proteasome inhibitor VL-01 against influenza A viruses.
Haasbach E; Pauli EK; Spranger R; Mitzner D; Schubert U; Kircheis R; Planz O
Antiviral Res; 2011 Sep; 91(3):304-13. PubMed ID: 21777621
[TBL] [Abstract][Full Text] [Related]
6. Generation and characterization of interferon-lambda 1-resistant H1N1 influenza A viruses.
Ilyushina NA; Lugovtsev VY; Samsonova AP; Sheikh FG; Bovin NV; Donnelly RP
PLoS One; 2017; 12(7):e0181999. PubMed ID: 28750037
[TBL] [Abstract][Full Text] [Related]
7. 2009 pandemic H1N1 influenza A virus strains display differential pathogenicity in C57BL/6J but not BALB/c mice.
Otte A; Gabriel G
Virulence; 2011; 2(6):563-6. PubMed ID: 22030859
[TBL] [Abstract][Full Text] [Related]
8. Full-length human surfactant protein A inhibits influenza A virus infection of A549 lung epithelial cells: A recombinant form containing neck and lectin domains promotes infectivity.
Al-Qahtani AA; Murugaiah V; Bashir HA; Pathan AA; Abozaid SM; Makarov E; Nal-Rogier B; Kishore U; Al-Ahdal MN
Immunobiology; 2019 May; 224(3):408-418. PubMed ID: 30954271
[TBL] [Abstract][Full Text] [Related]
9. Pregnant women have attenuated innate interferon responses to 2009 pandemic influenza A virus subtype H1N1.
Forbes RL; Wark PA; Murphy VE; Gibson PG
J Infect Dis; 2012 Sep; 206(5):646-53. PubMed ID: 22693225
[TBL] [Abstract][Full Text] [Related]
10. Type I interferon limits influenza virus-induced acute lung injury by regulation of excessive inflammation in mice.
Arimori Y; Nakamura R; Yamada H; Shibata K; Maeda N; Kase T; Yoshikai Y
Antiviral Res; 2013 Sep; 99(3):230-7. PubMed ID: 23721943
[TBL] [Abstract][Full Text] [Related]
11. In vitro sensitivity of human metapneumovirus to type I interferons.
Scagnolari C; Trombetti S; Selvaggi C; Carbone T; Monteleone K; Spano L; Di Marco P; Pierangeli A; Maggi F; Riva E; Antonelli G
Viral Immunol; 2011 Apr; 24(2):159-64. PubMed ID: 21449726
[TBL] [Abstract][Full Text] [Related]
12. Antiviral activity of recombinant mouse β-defensin 3 against influenza A virus in vitro and in vivo.
Jiang Y; Yang D; Li W; Wang B; Jiang Z; Li M
Antivir Chem Chemother; 2012 Aug; 22(6):255-62. PubMed ID: 22345365
[TBL] [Abstract][Full Text] [Related]
13. Protective efficacy of IFN-ω AND IFN-λs against influenza viruses in induced A549 cells.
Škorvanová L; Švančarová P; Svetlíková D; Betáková T
Acta Virol; 2015 Dec; 59(4):413-7. PubMed ID: 26666190
[TBL] [Abstract][Full Text] [Related]
14. Antibody and inflammatory response-mediated severity of pandemic 2009 (pH1N1) influenza virus.
Tiwari N; Kapoor P; Dhole TN
J Med Virol; 2014 Jun; 86(6):1034-40. PubMed ID: 24615905
[TBL] [Abstract][Full Text] [Related]
15. [Aprotinin-induced inhibition of pandemic influenza virus A(H1N1) reproduction].
Zhirnov OP; Klenk HD
Vopr Virusol; 2011; 56(3):24-8. PubMed ID: 21786623
[TBL] [Abstract][Full Text] [Related]
16. The potential for multidrug-resistant influenza.
van der Vries E; Schutten M; Boucher CA
Curr Opin Infect Dis; 2011 Dec; 24(6):599-604. PubMed ID: 22001947
[TBL] [Abstract][Full Text] [Related]
17. [Experimental study of Grippferon antiviral activity against Mexican pandemic influenza virus A/H1N1/2009 in vitro].
Loginova SIa; Borisevich SV; Shchukina VN; Borisevich GV; Bondarev VP; Shevtsov VA
Antibiot Khimioter; 2011; 56(5-6):7-10. PubMed ID: 22145225
[TBL] [Abstract][Full Text] [Related]
18. Interferon-β modulates type 1 immunity during influenza virus infection.
Yoo JK; Baker DP; Fish EN
Antiviral Res; 2010 Oct; 88(1):64-71. PubMed ID: 20659503
[TBL] [Abstract][Full Text] [Related]
19. Antibodies against swine influenza virus neutralize the pandemic influenza virus A/H1N1.
Tsukamoto M; Hiroi S; Adachi K; Kato H; Inai M; Konishi I; Tanaka M; Yamamoto R; Sawa M; Handharyani E; Tsukamoto Y
Mol Med Rep; 2011; 4(2):209-14. PubMed ID: 21468553
[TBL] [Abstract][Full Text] [Related]
20. Innate and adaptive immune responses in patients with pandemic influenza A(H1N1)pdm09.
Huang Y; Zhu W; Zeng X; Li S; Li X; Lu C
Arch Virol; 2013 Nov; 158(11):2267-72. PubMed ID: 23728719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
